The Asia-Pacific Anticoccidial Drugs Market is expected to register a CAGR of 4.4% during the forecast period. Coccidiosis is a parasitic infection of the intestinal tract of animals which is caused by coccidian protozoa. The disease spreads from one animal to another by means of infected faeces or ingestion of infected tissue. To overcome this condition, anticoccidial drugs play a key role in the treatment and prevention of coccidiosis.

As per the study report in Science daily 2019, stated that since 2000, meat production has increased by more than 60% in Africa and Asia, and by 40% in South America, as countries shifted from low- to high-protein diets thus, driving the growth of the market. More than half of the world’s chickens and pigs are in Asia.

The major factors driving the growth of the market in the Asia region is due to the rising incidence of coccidiosis in food-producing animals and companion animals, increased demand for meat proteins in countries like China, India, Malaysia, etc.

However, the use of alternative treatments, such as vaccines and herbal remedies, to treat Coccidiosis is likely to hamper the growth of the anticoccidial drugs market.

Key Market Trends


Ionophore Anticoccidial Segment is Expected to dominate the Anticoccidial Drugs Market Over The Forecast Period

These drugs are widely used for the prevention of coccidiosis, due to its broad-spectrum activity against the majority of pathogenic species of coccidian and lack of development of drug resistance. Each has a different mode of action and no significant resistance has been developed. These drugs are commonly added to the starter and grower feeds, but not to the finisher or withdrawal feeds.

For many years, ionophores have been the choice to control coccidiosis because resistance develops slowly because they do not completely suppress parasite development, thus allowing the development of immunity in the host after first exposure.

In Australia, Elanco offers "Maxiban" is a unique combination product for coccidiosis prevention in broilers. Thus, owing to the above factors the segment is expected to grow over the forecast period.

Competitive Landscape


The Asia-Pacific Anticoccidial Market is competitive. Major market players are primarily focusing on continuous product development, while adopting growth strategies, such as mergers, acquisitions, and partnerships with other market players. Major players include Bayer Animal Healthcare, Boehringer Ingelheim, Elanco Animal Health, Merck, Virbac, and Zoetis Animal Healthcare, among others.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support